Filing Flows › Comparisons › HODO vs HSCS
House of Doge vs HeartSciences: HODO and HSCS compared
House of Doge is the larger company: $38K of revenue in its latest quarter (Q2 2026) against $2K for HeartSciences (Q1 FY27).
Where the money goes: HODO and HSCS
House of Doge (HODO) · Q2 2026
House of Doge, Q2 2026: revenue $38K, net earnings $4.0M, operating cash flow −$1.6M. The chart follows the revenue to costs, profit and cash.
HeartSciences (HSCS) · Q1 FY27
HeartSciences, Q1 FY27: revenue $2K (+10% year over year), net loss $3.2M, operating cash flow −$1.3M. The chart follows the revenue to costs, profit and cash.
| House of Doge (HODO) | HeartSciences (HSCS) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q1 FY27 |
| Revenue | $38K | $2K |
| Revenue growth, Y/Y | — | +10% |
| Operating margin | n/m | n/m |
| Net earnings | $4.0M | −$3.2M |
| Operating cash flow | −$1.6M | −$1.3M |
Questions
Which is bigger, House of Doge or HeartSciences?
House of Doge is the larger company: $38K of revenue in its latest quarter (Q2 2026) against $2K for HeartSciences (Q1 FY27).
More: House of Doge earnings · how House of Doge makes money · HeartSciences earnings · how HeartSciences makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Sep 14, 2026). Fiscal quarters can end on different dates. Not investment advice.